Found: 36
Select item for more details and to access through your institution.
Urokinase-type plasminogen activator and its inhibitor PAI-1: Predictors of poor response...
- Published in:
- JNCI: Journal of the National Cancer Institute, 1995, v. 87, n. 10, p. 751, doi. 10.1093/jnci/87.10.751
- By:
- Publication type:
- Article
DNA-synthesis enzyme activity: A biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?
- Published in:
- International Journal of Cancer, 1997, v. 74, n. 2, p. 156, doi. 10.1002/(SICI)1097-0215(19970422)74:2<156::AID-IJC3>3.0.CO;2-Y
- By:
- Publication type:
- Article
Prognostic significance of TP53 accumulation in human primary breast cancer: Comparison between a rapid quantitative immunoassay and SSCP analysis.
- Published in:
- International Journal of Cancer, 1996, v. 69, n. 2, p. 125, doi. 10.1002/(SICI)1097-0215(19960422)69:2<125::AID-IJC10>3.0.CO;2-8
- By:
- Publication type:
- Article
Expression of tumor-associated 90k-antigen in human breast cancer: No correlation with prognosis and response to first-line therapy with tamoxifen.
- Published in:
- International Journal of Cancer, 1995, v. 64, n. 2, p. 130, doi. 10.1002/ijc.2910640210
- By:
- Publication type:
- Article
Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2007, v. 29, n. 4, p. 341, doi. 10.1002/hed.20527
- By:
- Publication type:
- Article
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
- Published in:
- Scientific Reports, 2016, p. 32027, doi. 10.1038/srep32027
- By:
- Publication type:
- Article
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 148, n. 1, p. 19, doi. 10.1007/s10549-014-3142-0
- By:
- Publication type:
- Article
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 1, p. 39, doi. 10.1007/s10549-013-2529-7
- By:
- Publication type:
- Article
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 3, p. 843, doi. 10.1007/s10549-011-1663-3
- By:
- Publication type:
- Article
Prevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non- BRCA1/ BRCA2 breast cancer families.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 128, n. 1, p. 79, doi. 10.1007/s10549-010-1080-z
- By:
- Publication type:
- Article
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 127, n. 1, p. 43, doi. 10.1007/s10549-010-0940-x
- By:
- Publication type:
- Article
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 116, n. 2, p. 263, doi. 10.1007/s10549-008-0125-z
- By:
- Publication type:
- Article
TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 113, n. 2, p. 253, doi. 10.1007/s10549-008-9934-3
- By:
- Publication type:
- Article
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 111, n. 3, p. 429, doi. 10.1007/s10549-007-9800-8
- By:
- Publication type:
- Article
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
- Published in:
- Breast Cancer Research, 2012, v. 14, n. 5, p. 1, doi. 10.1186/bcr3317
- By:
- Publication type:
- Article
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 4, p. 1648, doi. 10.1172/JCI74440
- By:
- Publication type:
- Article
Prognostic value of CD44 variant expression in primary breast cancer.
- Published in:
- International Journal of Cancer, 1999, v. 84, n. 3, p. 209, doi. 10.1002/(SICI)1097-0215(19990621)84:3<209::AID-IJC2>3.0.CO;2-9
- By:
- Publication type:
- Article
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 10, p. 1487, doi. 10.2967/jnumed.115.160739
- By:
- Publication type:
- Article
A New Proposal for Multivariable Modelling of Time-Varying Effects in Survival Data Based on Fractional Polynomial Time-Transformation.
- Published in:
- Biometrical Journal, 2007, v. 49, n. 3, p. 453, doi. 10.1002/bimj.200610328
- By:
- Publication type:
- Article
KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 169, p. 1, doi. 10.1126/scitranslmed.3004688
- By:
- Publication type:
- Article
Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170536
- By:
- Publication type:
- Article
The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161731
- By:
- Publication type:
- Article
TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients.
- Published in:
- Genes, Chromosomes & Cancer, 1996, v. 16, n. 3, p. 170, doi. 10.1002/(SICI)1098-2264(199607)16:3<170::AID-GCC3>3.0.CO;2-W
- By:
- Publication type:
- Article
Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus.
- Published in:
- PLoS Genetics, 2010, v. 6, n. 7, p. 1, doi. 10.1371/journal.pgen.1001029
- By:
- Publication type:
- Article
Individual participant data meta-analysis for external validation, recalibration, and updating of a flexible parametric prognostic model.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Multilevel mixed effects parametric survival models using adaptive Gauss-Hermite quadrature with application to recurrent events and individual participant data meta-analysis.
- Published in:
- Statistics in Medicine, 2014, v. 33, n. 22, p. 3844, doi. 10.1002/sim.6191
- By:
- Publication type:
- Article
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Comparative Proteome Analysis Revealing an 11-Protein Signature for AggressiveTriple-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 2, p. 1, doi. 10.1093/jnci/djt376
- By:
- Publication type:
- Article
Clinical relevance of the urokinase plasminogen activator system in breast cancer.
- Published in:
- APMIS, 1999, v. 107, n. 1-6, p. 150, doi. 10.1111/j.1699-0463.1999.tb01538.x
- By:
- Publication type:
- Article
Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 3, p. 295, doi. 10.1002/1878-0261.12037
- By:
- Publication type:
- Article
LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 8, p. 1363, doi. 10.1016/j.molonc.2016.07.004
- By:
- Publication type:
- Article
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 1, p. 24, doi. 10.1016/j.molonc.2015.07.004
- By:
- Publication type:
- Article
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 6, p. 1218, doi. 10.1016/j.molonc.2015.02.006
- By:
- Publication type:
- Article